Applications

1772 – Single chamber leadless pacing with atrio-ventricular synchronous pacing in patients with bradycardia

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Assessment
  • Type New application
  • Pre-PASC consultation Closed
  • Pre-MSAC consultation Open
  • Outcome Pending

Application details

Applicant

Medtronic Australasia Pty Ltd

Reason for application

Request for funding through the Prescribed List.

Service or technology in this application

The atrio-ventricular (AV) leadless pacemaker is a single-chamber implantable transcatheter pacemaker inserted via the femoral vein and implanted directly into the right ventricular myocardium negating the need for transvenous wires. The AV leadless pacemaker uses mechanical sensing of atrial events to provide “AV synchronous” ventricular pacing.

Type: Therapeutic technology

Medical condition this application addresses

Bradycardia is defined as abnormally slow heart rhythm, as a consequence of the disturbance of the generation or conduction of cardiac electrical activity. AV block occurs when there is partial or complete interruption of impulse transmission from the atrium to the ventricle. Patients with bradycardia due to AV block are indicated for permanent pacing, which works by preventing the heart from beating slower than a predefined rate, by delivering an electrical stimulus to the myocardium when required.

Consultation survey and deadlines

The following consultation deadlines apply:

  • Pre-PASC consultation deadline: 15 March 2024
  • Pre-MSAC consultation deadline: Friday 14 February 2025 11:59 pm AEDT

For other ways to provide input, see how to have your say.

We welcome input from everyone. We are especially keen to hear from those with lived experience of the health condition, service or technology the applications are addressing.

Find out more about consultation.

Meetings to consider this application

  • PASC meeting: 18 to 19 April 2024
  • ESC meeting: 13 to 14 February 2025
  • MSAC meeting: 3 to 4 April 2025